Hoba Therapeutics Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $25M

  • Investors
  • 7

Hoba Therapeutics General Information

Description

Developer of medical therapeutics designed to assist in neuropathic pain and CNS disorders treatments. The company specializes in developing novel biopharmaceuticals for the relief, prevention, and treatment of chronic pain and hearing loss, and advancing a novel therapeutic protein targeting the cells, enabling medical practitioners with innovative, effective, safe, and disease-modifying treatments for patients living with neuropathic pain.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Ole Maaløesvej
  • 2200 Copenhagen
  • Denmark
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • Ole Maaløesvej
  • 2200 Copenhagen
  • Denmark

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hoba Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series A) 11-Dec-2023 $25M Completed Clinical Trials - Phase 1
6. Secondary Transaction - Private Completed Clinical Trials - Phase 1
5. Later Stage VC 07-Jul-2022 Completed Clinical Trials - Phase 1
4. Grant 16-Jun-2021 Completed Clinical Trials - Phase 1
3. Seed Round 22-May-2019 Completed Clinical Trials - Phase 1
2. Seed Round 20-Sep-2018 $4M $6.03M Completed Pre-Clinical Trials
1. Seed Round 02-Dec-2016 $2.03M $2.03M Completed Pre-Clinical Trials
To view Hoba Therapeutics’s complete valuation and funding history, request access »

Hoba Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
Ordinary 215,384 $9.46 $9.46 1x $9.46 9.07%
To view Hoba Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Hoba Therapeutics Patents

Hoba Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2022405685-A1 Treatment of nociceptive pain Pending 10-Dec-2021
CA-3239550-A1 Treatment of nociceptive pain Pending 10-Dec-2021
EP-4444338-A1 Treatment of nociceptive pain Pending 10-Dec-2021
US-20250325627-A1 Treatment of nociceptive pain Pending 10-Dec-2021
WO-2023104960-A1 Treatment of nociceptive pain Inactive 10-Dec-2021 A61K38/1709
To view Hoba Therapeutics’s complete patent history, request access »

Hoba Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hoba Therapeutics Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Indaco Venture Partners Venture Capital Minority
Medical Incubator Japan Venture Capital Minority
Eir Ventures Venture Capital Minority
European Innovation Council Accelerator/Incubator Minority
Denmark's Export and Investment Fund Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Hoba Therapeutics FAQs

  • When was Hoba Therapeutics founded?

    Hoba Therapeutics was founded in 2016.

  • Where is Hoba Therapeutics headquartered?

    Hoba Therapeutics is headquartered in Copenhagen, Denmark.

  • What is the size of Hoba Therapeutics?

    Hoba Therapeutics has 9 total employees.

  • What industry is Hoba Therapeutics in?

    Hoba Therapeutics’s primary industry is Drug Discovery.

  • Is Hoba Therapeutics a private or public company?

    Hoba Therapeutics is a Private company.

  • What is the current valuation of Hoba Therapeutics?

    The current valuation of Hoba Therapeutics is .

  • What is Hoba Therapeutics’s current revenue?

    The current revenue for Hoba Therapeutics is .

  • How much funding has Hoba Therapeutics raised over time?

    Hoba Therapeutics has raised $31M.

  • Who are Hoba Therapeutics’s investors?

    Indaco Venture Partners, Medical Incubator Japan, Eir Ventures, European Innovation Council, and Denmark's Export and Investment Fund are 5 of 7 investors who have invested in Hoba Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process